UR Business Network Interview – Xenetic BioSciences
Frank Magliochetti recently co-hosted the show Mind Your Own Business on the UR Business Network with show host and UR Business Network founder Rick Brutti.
Frank brought along two innovative pioneers in their respective fields for some interesting and lively conversations.
Meet Xenetic CEO Scott Maguire and listen to how what Xenetic is doing may impact the Boston Financial landscape.
CLICK HERE – to listen to the interview!
Xenetic is a leading UK-based bio pharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
Protein drugs and vaccines
Xenetic’s biopharmaceutical pipeline contains a range of product candidates which are currently under development either in-house or with biotechnology and pharmaceutical partners. The products in Xenetic’s pipeline have a multi-billion dollar market potential.
Frank Magliochetti is managing partner at Parcae Capital.
Parcae Capital offers personalized investment banking services for emerging growth companies. We specialize in finding companies which have leading edge technology, services or intellectual property in the healthcare, media and alternative energy space. We assist both public and private companies in preparing to raise private and public capital for all phases of growth. Parcae Capital also offers comprehensive assistance in mergers, acquisitions and related services. Our work out group specializes in business restructuring and recapitalization.